Onvitrelin ucalontide
Onvitrelin ucalontide is under investigation in clinical trial NCT01485848, EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian Cancer. Reference standards of Onvitrelin Ucalontide API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Onvitrelin ucalontide
[catalogue_number] => PA PEP 001233
[category_ids] => ,114,
[chemical_name] =>
[weight] => 3317.01
[form] => C163H243N43O32
[cas] => 1174415-90-7
[pslug] => 1174415-90-7-onvitrelin-ucalontide-papep001233
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA PEP 001233
Molecular Formula : C163H243N43O32
Molecular Weight : 3317.01